Di-n-butyl phthalate (DnBP) and diisobutyl phthalate (DiBP) metabolism in a human volunteer after single oral doses

Archives of Toxicology

Volumn 86, Issue 12, 2012, Pages 1829-1839

  Koch, H M ^a   Christensen, K L Y ^b   Harth, V ^a,c   Lorber, M ^b   Bruning T ^a  

^a INSTITUT DER RUHR UNIVERSITÄT BOCHUM IPA   (Germany)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

DiBP; DnBP; Human biomonitoring; Metabolism; Phthalate

Indexed keywords

BIOLOGICAL MARKER; DIISOBUTYLPHTHALATE; ESTER DERIVATIVE; MONOESTER; PHTHALIC ACID DERIVATIVE; PHTHALIC ACID DIBUTYL ESTER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHEMICAL MODIFICATION; HALF LIFE TIME; HUMAN; HUMAN EXPERIMENT; MALE; METABOLISM; METABOLITE; NORMAL HUMAN; OXIDATION; PRIORITY JOURNAL; TOXICOKINETICS; URINARY EXCRETION; URINE LEVEL; VOLUNTEER;

ADULT; CREATININE; DIBUTYL PHTHALATE; ENVIRONMENTAL MONITORING; HALF-LIFE; HUMANS; INDICATORS AND REAGENTS; MALE; OXIDATION-REDUCTION; PLASTICIZERS;

EID: 84871229528     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-012-0908-1     Document Type: Article

References (57)

1. Anderson WAC, Castle L, Scotter MJ, Massey RC, Springall C (2001) A biomarker approach to measuring human dietary exposure to certain phthalate diesters. Food Addit Contam 18(12):1068-1074. doi:10.1080/02652030110050113.
2. Calafat AM, Silva MJ, Reidy JA et al (2006) Mono-(3-carboxypropyl) phthalate, a metabolite of dinoctyl phthalate. J Toxicol Environ Health A Curr Issues 69(3):215-227. doi:10.1080/15287 390500227381.
3. Clark K, David RM, Guinn R, Kramarz KW, Lamp MA, Staples CA (2012) Modelling human exposure to phthalate esters: a comparison of indirect and biomonitoring estimation methods. J Hum Ecol Risk Assess 17(4):923-965. doi:10.1080/10807039.2011.588157
4. ECB (2004) Dibutyl phthalate. Vol. 1st priority list volume 29. EUR 19840 EN. European Union risk assessment report. European Chemicals Bureau.
5. EFSA (2005) Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request from the Commission related to Di-Butylphthalate (DBP) for use in food contact materials. Question No. EFSAQ- 2003-192. EFSA J 242:1-17. European Food Safety Authority.
6. Engel SM, Miodovnik A, Canfield RL et al (2010) Prenatal phthalate exposure is associated with childhood behavior and executive functioning. Environ Health Perspect 118(4):565-571. doi:10.1289/Ehp.0901470.
7. EPA (1990) Dibutyl phthalate (CASRN 84-74-2). United States Environmental Protection Agency, Integrated Risk Information System. http://www.epa.gov/iris/ subst/0038.htm. Accessed July 2012.
8. Habert R, Muczynski V, Lehraiki A et al (2009) Adverse effects of endocrine disruptors on the foetal testis development: focus on the phthalates. Folia Histochem Cytobiol 47(5):S67-S74. doi: 10.2478/v10042-009-0056-5.
9. Hatch EE, Nelson JW, Qureshi MM et al (2008) Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999-2002. Environ Health Glob 7. doi:10.1186/1476-069x-7-27.
10. Hauser R, Calafat AM (2005) Phthalates and human health. Occup Environ Med 62(11). doi:10.1136/oem.2004.017590.
11. Hauser R, Meeker JD, Duty S, Silva MJ, Calafat AM (2006) Altered semen quality in relation to urinary concentrations of phthalate monoester and oxidative metabolites. Epidemiology 17(6):682- 691. doi:10.1097/01.ede. 0000235996.89953.d7.
12. Heikkila P, Kemppainen T, Kirsila T, Korhonen P (2010) BeST- Bioequivalence Study Templat. Paper presented at the Pharmaceutical Users Software Exchange, Berlin, Germany, October 14-17, 2010.
13. Hernandez-Diaz S, Mitchell AA, Kelley KE, Calafat AM, Hauser R (2009) Medications as a potential source of exposure to phthalates in the US population. Environ Health Perspect 117(2):185-189. doi:10.1289/Ehp.11766.
14. Hong YC, Park EY, Park MS et al (2009) Community level exposure to chemicals and oxidative stress in adult population. Toxicol Lett 184(2):139-144. doi:10.1016/j.toxlet.2008.11.001.
15. Huang PC, Kuo PL, Chou YY, Lin SJ, Lee CC (2009) Association between prenatal exposure to phthalates and the health of newborns. Environ Int 35(1):14-20. doi:10.1016/j.envint.2008. 05.012.
16. Huang PC, Tsai EM, Li WF et al (2010) Association between phthalate exposure and glutathione S-transferase M1 polymorphism in adenomyosis, leiomyoma and endometriosis. Hum Reprod 25(4):986-994. doi:10.1093/humrep/deq015.
17. Kasper-Sonnenberg M, Koch HM, Wittsiepe J, Wilhelm M (2012) Levels of phthalate metabolites in urine among mother-childpairs- results from the Duisburg birth cohort study, Germany. Int J Hyg Environ Health 215(3):373-382. doi:10.1016/j.ijheh. 2011.09.004.
18. Kavlock R, Boekelheide K, Chapin R et al (2002) NTP Center for the evaluation of risks to human reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di-n-butyl phthalate. Reprod Toxicol 16(5):489-527. doi:10.1016/S0890-6238(02)00033-3.
19. Kelley KE, Hernandez-Diaz S, Chaplin EL, Hauser R, Mitchell AA (2011) Identification of phthalates in medications and dietary supplements. Pharmacoepidemiol Drug Saf 20:S37.
20. Kim BN, Cho SC, Kim Y et al (2009) Phthalates exposure and attention-deficit/hyperactivity disorder in school-age children. Biol Psychiatry 66(10):958-963. doi:10.1016/j.biopsych.2009. 07.034.
21. Kim Y, Kim BN, Kim EJ et al (2011) Perinatal exposure to environmental phthalate and the cognitive development of 6-month-old infants (MOCEH Study). Epidemiology 22(1):S285.
22. Koch HM, Angerer J (2007) Di-iso-nonylphthalate (DINP) metabolites in human urine after a single oral dose of deuterium-labelled DINP. Int J Hyg Environ Health 210(1):9-19. doi:10.1016/j.ijheh.2006.11.008.
23. Koch HM, Calafat AM (2009) Human body burdens of chemicals used in plastic manufacture. Philos Trans R Soc B Biol Sci 364(1526):2063-2078. doi:10.1098/rstb.2008.0208.
24. Koch HM, Bolt HM, Angerer J (2004) Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP. Arch Toxicol 78(3):123-130. doi:10.1007/00204-003-0522- 3.
25. Koch HM, Bolt HM, Preuss R, Angerer J (2005a) New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP. Arch Toxicol 79(7):367-376. doi:10.1007/s00204-004-0642-4.
26. Koch HM, Preuss R, Drexler H, Angerer J (2005b) Exposure of nursery school children and their parents and teachers to di-nbutylphthalate and butylbenzylphthalate. Int Arch Occup Environ Health 78(3):223-229. doi:10.1007/s00420-004-0570-x.
27. Koch HM, Becker K, Wittassek M, Seiwert M, Angerer J, Kolossa- Gehring M (2007a) Di-n-butylphthalate and butylbenzylphthalate- urinary metabolite levels and estimated daily intakes: pilot study for the German Environmental Survey on children. J Eposure Sci Environ Epidemiol 17(4):378-387. doi:10.1038/sj.jes. 7500526.
28. Koch HM, Muller J, Angerer J (2007b) Determination of secondary, oxidised di-iso-nonylphthalate (DINP) metabolites in human urine representative for the exposure to commercial DINP plasticizers. J Chromatogr B 847(2):114-125. doi:10.1016/j.jchromb. 2006.09.044.
29. Koch HM, Haller A, Weiß T, Käfferlein HU, Stork J, Brüning T (2012) Phthalate exposure during cold plastisol application-A human biomonitoring study. Toxicol Lett. doi:10.1016/j.toxlet. 2011.06.010.
30. Larsen K (1972) Creatinine assay by a reaction-kinetic principle. Clin Chim Acta 41(1):209-217.
31. Lorber M, Angerer J, Koch HM (2010) A simple pharmacokinetic model to characterize exposure of Americans to Di-2-ethylhexyl phthalate. J Eposure Sci Environ Epidemiol 20(1):38-53. doi: 10.1038/jes.2008.74.
32. Lorber M, Koch HM, Angerer J (2011) A critical evaluation of the creatinine correction approach: can it underestimate intakes of phthalates? A case study with di-2-ethylhexyl phthalate. J Eposure Sci Environ Epidemiol 21(6):576-586. doi:10.1038/Jes. 2010.43.
33. Lyche JL, Gutleb AC, Bergman A et al (2009) Reproductive and developmental toxicity of phthalates. J Toxicol Environ Health B Crit Rev 12(4):225-249. doi:10.1080/10937400903094091.
34. Martino-Andrade AJ, Chahoud I (2010) Reproductive toxicity of phthalate esters. Mol Nutr Food Res 54(1):148-157. doi: 10.1002/mnfr.200800312.
35. Meeker JD, Hu H, Cantonwine DE et al (2009a) Urinary phthalate metabolites in relation to preterm birth in Mexico City. Environ Health Perspect 117(10):1587-1592. doi:10.1289/Ehp.0800522.
36. Meeker JD, Sathyanarayana S, Swan SH (2009b) Phthalates and other additives in plastics: human exposure and associated health outcomes. Philos Trans R Soc B Biol Sci 364(1526):2097-2113. doi:10.1098/rstb.2008.0268.
37. Miodovnik A, Engel SM, Zhu CB et al (2011) Endocrine disruptors and childhood social impairment. Neurotoxicology 32(2):261- 267. doi:10.1016/j.neuro.2010.12.009.
38. Pant N, Shukla M, Patel DK et al (2008) Correlation of phthalate exposures with semen quality. Toxicol Appl Pharmacol 231(1):112-116. doi:10.1016/j.taap.2008.04.001.
39. Pant N, Pant AB, Shukla M, Mathur N, Gupta YK, Saxena DK (2011) Environmental and experimental exposure of phthalate esters: the toxicological consequence on human sperm. Hum Exp Toxicol 30(6):507-514. doi:10.1177/ 0960327110374205.
40. SAS (2011) Version 9.3 of the SAS System for Windows. Copyright -2011 SAS Institute Inc. SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc., Cary, NC, USA.
41. Schütze A, Palmke C, Angerer J, Weiss T, Brüning T, Koch HM (2012) Quantification of biomarkers of environmental exposure to di(isononyl)cyclohexane-1, 2-dicarboxylate (DINCH) in urine via LC/LC-MS/MS. J Chromatogr B doi:10.1016/j.jchromb. 2012.03.030.
42. Seckin E, Fromme H, Volkel W (2009) Determination of total and free mono-n-butyl phthalate in human urine samples after medication of a di-n-butyl phthalate containing capsule. Toxicol Lett 188(1):33-37. doi:10.1016/j.toxlet. 2009.03.002.
43. Silva MJ, Barr DB, Reidy JA et al (2004) Urinary levels of seven phthalate metabolites in the US population from the National Health and Nutrition Examination Survey (NHANES) 1999- 2000. Environ Health Perspect 112(3):331-338. doi:10.1289/ehp.6723.
44. Silva MJ, Reidy JA, Samandar E, Herbert AR, Needham LL, Calafat AM (2005a) Detection of phthalate metabolites in human saliva. Arch Toxicol 79(11):647-652. doi:10.1007/s00204-005-0674-4.
45. Silva MJ, Samandar E, Preau JL, Reidy JA, Needham LL, Calafat AM (2005b) Automated solid-phase extraction and quantitative analysis of 14 phthalate metabolites in human serum using isotope dilution-high-performance liquid chromatography-tandem mass spectrometry. J Anal Toxicol 29(8):819-824. doi: 10.1093/jat/29.8.819.
46. Silva MJ, Samandar E, Reidy JA, Hauser R, Needham LL, Calafat AM (2007) Metabolite profiles of di-n-butyl phthalate in humans and rats. Environ Sci Technol 41(21):7576-7580. doi:10.1021/Es071142x.
47. Silva MJ, Furr J, Samandar E et al (2011) Urinary and serum metabolites of di-n-pentyl phthalate in rats. Chemosphere 82(3):431-436. doi:10.1016/j.chemosphere.2010.09.052.
48. Stahlhut RW, van Wijngaarden E, Dye TD, Cook S, Swan SH (2007) Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult US males. Environ Health Perspect 115(6):876-882. doi: 10.1289/ehp.9882.
49. Swan SH (2008) Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans. Environ Res 108(2):177-184. doi:10.1016/j.envres.2008.08.007.
50. Swan SH, Main KM, Liu F et al (2005) Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect 113(8):1056-1061. doi:10.1289/ehp.8100.
51. Weuve J, Hauser R, Calafat AM, Missmer SA, Wise LA (2010) Association of exposure to phthalates with endometriosis and uterine leiomyomata: findings from NHANES, 1999-2004. Environ Health Perspect 118(6):825-832. doi:10.1289/Ehp. 0901543.
52. Whyatt R, Arias F, Calafat A, Rauh V, Factor-Litvak P (2011) Associations between maternal prenatal phthalate urinary metabolite concentrations and child mental and motor development at age 3 years. Epidemiology 22(1):S126-S127.
53. Wittassek M, Koch HM, Angerer J, Bruning T (2011) Assessing exposure to phthalates-the human biomonitoring approach. Mol Nutr Food Res 55(1):7-31. doi:10.1002/mnfr.201000121.
54. Wolff MS, Teitelbaum SL, Pinney SM et al (2010) Investigation of relationships between urinary biomarkers of phytoestrogens, phthalates, and phenols and pubertal stages in girls. Environ Health Perspect 118(7):1039-1046. doi:10.1289/ehp.0901690.
55. Wormuth M, Scheringer M, Vollenweider M, Hungerbuhler K (2006) What are the sources of exposure to eight frequently used phthalic acid esters in Europeans? Risk Anal 26(3):803-824. doi: 10.1111/j.1539-6924.2006.00770.x.
56. Zhang YH, Zheng LX, Chen BH (2006) Phthalate exposure and human semen quality in Shanghai: a cross-sectional study. Biomed Environ Sci 19(3):205-209.
57. Zhang YH, Lin L, Cao Y, Chen BH, Zheng LX, Ge RS (2009) Phthalate levels and low birth weight: a nested case-control study of chinese newborns. J Pediatr 155(4):500-504. doi:10.1016/j.jpeds.2009.04.007.